HLTH Europe 2026: enriching the patient journey with health technologies
With the pharma, biotech and medtech sectors debuting new and potentially life-changing innovations for patients at a rapid pace, many …
With the pharma, biotech and medtech sectors debuting new and potentially life-changing innovations for patients at a rapid pace, many …
Neko Health has introduced new body composition and wearables integration features to its health scan service, marking what it describes …
Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, assessing the role of early mechanical thrombectomy …
On 17 March, the Vascular and Venous Disease All-Party Parliamentary Group (VVAPPG) launched a whitepaper setting out a roadmap for …
ZEISS Medical Technology and Envision Health Technology are joining forces to advance glaucoma care with gamified virtual reality (VR). The German …
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ leakage issue associated with …
Chemomouthpiece, a medical device company focused on supportive oncology care, has formed a partnership with Zeal Specialty Pharmacy to expand …
Charles River Laboratories International has entered a collaboration with Eli Lilly and Company’s artificial intelligence / machine learning (AI/ML)-focused drug …
Novocure’s stock has dropped more than 15% after its Phase III glioblastoma study of Optune Gio failed to show benefit …
FiberSense has obtained a CE mark for its continuous glucose monitoring (CGM) system, setting the stage for the medical device’s …
In January 2026, the American Heart and American Stroke Association (AHA/ASA) issued new care guidelines for acute ischemic stroke (AIS) …
The government of Japan has inducted Sonire Therapeutics’ Japan-based group into an innovation programme, along with equipping the company with …
Australian healthcare company BCAL Diagnostics is developing the BREASTEST Monitor blood test intended to assist in evaluating women for local …
AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption application to begin …
WISE has raised €30m ($34.8m) to advance the development of its spinal cord stimulation (SCS) device for chronic pain treatment. The …